Skip to main content
. 2021 Oct 27;2021:2549541. doi: 10.1155/2021/2549541

Table 3.

The effect of B. subtilis supplementation on growth performance and mortality in CP-challenged broilers.

Treatment1 Control group CP-challenged model group Antibiotics
(positive control group)
B. subtilis PB6 low-dosage group B. subtilis PB6 high-dosage group SEM2 P value3
d1-d18 nonchallenge phase
 BWG (g) 36.06 35.47 35.44 35.14 35.58 0.25 0.86
 FI (g) 51.61 50.87 51.65 51.79 51.97 0.44 0.95
 FCR 1.43 1.44 1.46 1.48 1.46 0.01 0.50
 Mortality rate 0.00 0.00 0.00 0.00 0.00 0.00 1.00
d19-d26 challenge phase
 BWG (g) 66.12a 54.95c 59.21bc 61.62ab 62.86ab 1.087 0.009
 FI (g) 109.55a 99.90bc 98.35c 106.30ab 108.41a 1.305 0.007
 FCR 1.66 1.83 1.67 1.73 1.73 0.02 0.062
 Mortality rate (%) 2.22 3.49 1.11 4.45 3.58 0.907 0.821
Overall
 BWG (g) 46.47a 42.21c 43.67bc 44.31abc 45.02ab 0.394 0.004
 FI (g) 71.66a 67.84b 67.81b 70.66ab 71.51a 0.544 0.026
 FCR 1.55 1.61 1.55 1.6 1.59 0.009 0.151
 Mortality rate (%) 2.22 3.49 1.11 4.45 3.58 0.907 0.821

1Treatment information: control group: basal diet; CP-challenged model group: basal diet and CP challenge; antibiotics (positive control group): CP challenge+10 mg/kg enramycin; B. subtilis PB6 low-dosage group: CP challenge+4 × 107 CFU/kg of feed B. subtilis PB6; B. subtilis PB6 high-dosage group: CP challenge+6 × 107 CFU/kg of feed B. subtilis PB6. BWG: body weight gain; FI: feed intake; FCR: feed conversion ratio. 2Standard error of the means; n = 6 chickens/group. 3Mean values within a column with unlike superscripts letters (a, b, and c) are significantly different (P < 0.05).